BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 18405471)

  • 1. The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation.
    Hockenhull JC; Dwan K; Boland A; Smith G; Bagust A; Dündar Y; Gamble C; McLeod C; Walley T; Dickson R
    Health Technol Assess; 2008 Apr; 12(12):iii-iv, xi-xii, 1-154. PubMed ID: 18405471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: a systematic review.
    Hockenhull JC; Dwan KM; Smith GW; Gamble CL; Boland A; Walley TJ; Dickson RC
    Crit Care Med; 2009 Feb; 37(2):702-12. PubMed ID: 19114884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New choices for central venous catheters: potential financial implications.
    Shorr AF; Humphreys CW; Helman DL
    Chest; 2003 Jul; 124(1):275-84. PubMed ID: 12853534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.
    Lai NM; Chaiyakunapruk N; Lai NA; O'Riordan E; Pau WS; Saint S
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD007878. PubMed ID: 26982376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis.
    Walder B; Pittet D; Tramèr MR
    Infect Control Hosp Epidemiol; 2002 Dec; 23(12):748-56. PubMed ID: 12517018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT.
    Gilbert R; Brown M; Faria R; Fraser C; Donohue C; Rainford N; Grosso A; Sinha AK; Dorling J; Gray J; Muller-Pebody B; Harron K; Moitt T; McGuire W; Bojke L; Gamble C; Oddie SJ
    Health Technol Assess; 2020 Nov; 24(57):1-190. PubMed ID: 33174528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.
    Lai NM; Chaiyakunapruk N; Lai NA; O'Riordan E; Pau WS; Saint S
    Cochrane Database Syst Rev; 2013 Jun; (6):CD007878. PubMed ID: 23740696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-infective-treated central venous catheters for total parenteral nutrition or chemotherapy: a systematic review.
    Niël-Weise BS; Stijnen T; van den Broek PJ
    J Hosp Infect; 2008 Jun; 69(2):114-23. PubMed ID: 18439717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CATheter Infections in CHildren (CATCH): a randomised controlled trial and economic evaluation comparing impregnated and standard central venous catheters in children.
    Harron K; Mok Q; Dwan K; Ridyard CH; Moitt T; Millar M; Ramnarayan P; Tibby SM; Muller-Pebody B; Hughes DA; Gamble C; Gilbert RE
    Health Technol Assess; 2016 Mar; 20(18):vii-xxviii, 1-219. PubMed ID: 26935961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Efficacy of Antimicrobial Central Venous Catheters in Reducing Catheter-Related Bloodstream Infections in Adults: Abridged Cochrane Systematic Review and Network Meta-Analysis.
    Chong HY; Lai NM; Apisarnthanarak A; Chaiyakunapruk N
    Clin Infect Dis; 2017 May; 64(suppl_2):S131-S140. PubMed ID: 28475779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlorhexidine-silver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy.
    Lorente L; Lecuona M; Jiménez A; Cabrera J; Santacreu R; Lorenzo L; Raja L; Mora ML
    Am J Infect Control; 2016 Dec; 44(12):1526-1529. PubMed ID: 27378009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency of chlorhexidine-silver sulfadiazine-impregnated venous catheters at subclavian sites.
    Lorente L; Lecuona M; Jiménez A; Lorenzo L; Santacreu R; Ramos S; Hurtado E; Buitrago M; Mora ML
    Am J Infect Control; 2015 Jul; 43(7):711-4. PubMed ID: 25934065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-infective-treated central venous catheters: a systematic review of randomized controlled trials.
    Niël-Weise BS; Stijnen T; van den Broek PJ
    Intensive Care Med; 2007 Dec; 33(12):2058-68. PubMed ID: 17940746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of antimicrobial catheters in the intensive care unit: addressing uncertainty in the decision.
    Halton KA; Cook DA; Whitby M; Paterson DL; Graves N
    Crit Care; 2009; 13(2):R35. PubMed ID: 19284570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety of prolonging the use of central venous catheters: a prospective analysis of the effects of using antiseptic-bonded catheters with daily site care.
    Norwood S; Wilkins HE; Vallina VL; Fernandez LG; McLarty JW
    Crit Care Med; 2000 May; 28(5):1376-82. PubMed ID: 10834681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis.
    Casey AL; Mermel LA; Nightingale P; Elliott TS
    Lancet Infect Dis; 2008 Dec; 8(12):763-76. PubMed ID: 19022192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials.
    Falagas ME; Fragoulis K; Bliziotis IA; Chatzinikolaou I
    J Antimicrob Chemother; 2007 Mar; 59(3):359-69. PubMed ID: 17255143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
    Schumm K; Lam TB
    Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlorhexidine-silver sulfadiazine- or rifampicin-miconazole-impregnated venous catheters decrease the risk of catheter-related bloodstream infection similarly.
    Lorente L; Lecuona M; Jiménez A; Raja L; Cabrera J; Gonzalez O; Diosdado S; Marca L; Mora ML
    Am J Infect Control; 2016 Jan; 44(1):50-3. PubMed ID: 26412482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.
    Shepherd J; Jones J; Frampton GK; Tanajewski L; Turner D; Price A
    Health Technol Assess; 2008 Jun; 12(28):iii-iv, ix-95. PubMed ID: 18547499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.